JP2006328024A - 皮膚用外用剤 - Google Patents
皮膚用外用剤 Download PDFInfo
- Publication number
- JP2006328024A JP2006328024A JP2005157120A JP2005157120A JP2006328024A JP 2006328024 A JP2006328024 A JP 2006328024A JP 2005157120 A JP2005157120 A JP 2005157120A JP 2005157120 A JP2005157120 A JP 2005157120A JP 2006328024 A JP2006328024 A JP 2006328024A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- external preparation
- silk protein
- ubiquinone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 239000000284 extract Substances 0.000 claims abstract description 76
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 40
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 31
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 31
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229940035936 ubiquinone Drugs 0.000 claims abstract description 27
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 26
- 244000068988 Glycine max Species 0.000 claims abstract description 24
- 235000020712 soy bean extract Nutrition 0.000 claims abstract description 17
- 229940069445 licorice extract Drugs 0.000 claims abstract description 16
- 235000011203 Origanum Nutrition 0.000 claims abstract description 13
- 240000000783 Origanum majorana Species 0.000 claims abstract description 12
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 12
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 12
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 12
- 239000012138 yeast extract Substances 0.000 claims abstract description 12
- 240000002657 Thymus vulgaris Species 0.000 claims abstract 2
- 108010013296 Sericins Proteins 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 14
- 235000020710 ginseng extract Nutrition 0.000 claims description 12
- 235000013322 soy milk Nutrition 0.000 claims description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- 240000001548 Camellia japonica Species 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 3
- 235000018597 common camellia Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 24
- 230000009759 skin aging Effects 0.000 abstract description 12
- 230000020411 cell activation Effects 0.000 abstract description 7
- 240000004371 Panax ginseng Species 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 5
- 235000008434 ginseng Nutrition 0.000 abstract description 5
- 244000146462 Centella asiatica Species 0.000 abstract description 3
- 235000004032 Centella asiatica Nutrition 0.000 abstract description 3
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 3
- 235000013336 milk Nutrition 0.000 abstract description 2
- 239000008267 milk Substances 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 238000000605 extraction Methods 0.000 description 29
- 239000007864 aqueous solution Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 241000246358 Thymus Species 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 7
- 150000002515 isoflavone derivatives Chemical class 0.000 description 7
- 235000008696 isoflavones Nutrition 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 244000308760 Helichrysum petiolatum Species 0.000 description 5
- 235000013537 Helichrysum petiolatum Nutrition 0.000 description 5
- -1 Polyoxyethylene lauryl ether Polymers 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 235000020230 cinnamon extract Nutrition 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000003405 preventing effect Effects 0.000 description 5
- 230000037394 skin elasticity Effects 0.000 description 5
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 4
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 4
- 241000167550 Centella Species 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000008347 soybean phospholipid Substances 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 2
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 244000179970 Monarda didyma Species 0.000 description 2
- 235000010672 Monarda didyma Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000037319 collagen production Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 2
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- OWMHCYFEIJPHFB-UHFFFAOYSA-N malonyl glycitin Natural products COc1cc2c(cc1OC1OC(COC(=O)CC(O)=O)C(O)C(O)C1O)occ(-c1ccc(O)cc1)c2=O OWMHCYFEIJPHFB-UHFFFAOYSA-N 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000010668 rosemary oil Substances 0.000 description 2
- 229940058206 rosemary oil Drugs 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UIXPTCZPFCVOQF-UHFFFAOYSA-N ubiquinone-0 Chemical group COC1=C(OC)C(=O)C(C)=CC1=O UIXPTCZPFCVOQF-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- FRAUJUKWSKMNJY-UHFFFAOYSA-N 5-hydroxy-3-(4-hydroxyphenyl)-7-(6-malonyl-beta-D-glucopyranosyloxy)-4H-1-benzopyran-4-one Natural products OC1C(O)C(O)C(COC(=O)CC(O)=O)OC1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 FRAUJUKWSKMNJY-UHFFFAOYSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 235000005158 Thymus praecox ssp. arcticus Nutrition 0.000 description 1
- 240000006001 Thymus serpyllum Species 0.000 description 1
- 235000004054 Thymus serpyllum Nutrition 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DXWGBJJLEDQBKS-UHFFFAOYSA-N acetylgenistin Natural products OC1C(O)C(O)C(COC(=O)C)OC1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 DXWGBJJLEDQBKS-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- DUBPGEJGGVZKDD-PFKOEMKTSA-N glycitein 7-(6-O-acetyl-beta-D-glucoside) Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O DUBPGEJGGVZKDD-PFKOEMKTSA-N 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- MTXMHWSVSZKYBT-UHFFFAOYSA-N malonyl daidzin Natural products OC1C(O)C(O)C(COC(=O)CC(O)=O)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 MTXMHWSVSZKYBT-UHFFFAOYSA-N 0.000 description 1
- MTXMHWSVSZKYBT-ASDZUOGYSA-N malonyldaidzin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 MTXMHWSVSZKYBT-ASDZUOGYSA-N 0.000 description 1
- FRAUJUKWSKMNJY-RSEYPYQYSA-N malonylgenistin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 FRAUJUKWSKMNJY-RSEYPYQYSA-N 0.000 description 1
- OWMHCYFEIJPHFB-GOZZSVHWSA-N malonylglycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](COC(=O)CC(O)=O)[C@@H](O)[C@H](O)[C@H]1O OWMHCYFEIJPHFB-GOZZSVHWSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940095479 sweet marjoram extract Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
【解決手段】加水分解シルク蛋白質およびユビキノンを含有することを特徴とする皮膚外用剤。またさらに、甘草抽出物、大豆発酵抽出物、大豆抽出物、豆乳発酵抽出物、酵母抽出物、タイム抽出物、オタネニンジン抽出物、マジョラム抽出物、ツボクサ抽出物から選択される1種以上の成分を併用することにより、さらなる細胞賦活作用を付与することができる。
Description
本発明において用いる大豆発酵抽出物は、大豆(Glycine max Merrill)の種子を納豆菌(Bacillus natto sawamura)で発酵させて得た大豆発酵物を溶媒で抽出したものが用いられる。
(1)精製水 残量(重量%)
(2)グリセリン 8.0
(3)ジプロピレングリコール 6.0
(4)1,3−ブチレングリコール 10.0
(5)ポリクオタニウム−51 0.8
(6)キサンタンガム 0.05
(7)(アクリレーツ/アクリル酸アルキル(C10−30))
クロスポリマー 0.05
(8)カルボキシビニルポリマー 0.3
(9)水酸化カリウム 0.1
(10)テトラヘキシルデカン酸アスコルビル 0.2
(11)ミリスチン酸ポリグリセリル 0.15
(12)トリエチルヘキサノイン 0.05
(13)ジフェニルポリシロキサン・ジメチルポリシロキサン共重合体 0.3
(14)水酸化レシチン 0.05
(15)トコフェロール 0.01
(16)モノオレイン酸ポリオキシエチレンソルビタン 0.5
(17)トリ(カプリル/カプリン酸)グリセリル 0.25
(18)大豆リン脂質 0.4
(19)加水分解シルク蛋白質水溶液 5.0
(20)ユビキノン 2.0
(21)ヒアルロン酸ナトリウム 0.5
(22)水溶性コラーゲン 0.5
(23)甘草抽出物 0.1
(24)ワイルドタイム抽出物 0.1
(25)オタネニンジン抽出物 0.1
(26)マジョラム抽出物 0.1
(27)ツボクサ抽出物 0.1
(28)クエン酸 0.1
(29)マルチトール 0.8
(30)エタノール 2.0
(31)ベルガモット果実油 0.025
(32)ローズマリー油 0.025
(33)パラオキシ安息香酸メチル 0.15
(34)パラオキシ安息香酸プロピル 0.05
製法:(1)〜(9)の水相成分および(10)〜(18)の油相成分をそれぞれ85℃に加熱溶解する。水相成分に油相成分を添加し、ホモミキサーを用いて乳化する。50℃まで冷却し(19)〜(34)の成分を順次添加して混合,均質化する。
(1)精製水 残量(重量%)
(2)1,3−ブチレングリコール 8.0
(3)グリセリン 6.0
(4)キサンタンガム 0.1
(5)ポリクオタニウム−51 0.2
(6)ポリアクリル酸アミド 0.5
(7)スクワラン 5.0
(8)トリ2−エチルヘキサン酸グリセリル 4.5
(9)軽質流動イソパラフィン 3.0
(10)ポリオキシエチレンラウリルエーテル 1.5
(11)高重合メチルポリシロキサン 2.0
(12)トコフェロール 0.05
(13)マカデミアンナッツ油 0.3
(14)ホホバ油 0.3
(15)オリーブ油 0.3
(16)ローズヒップ油 0.3
(17)テトラヒドロキシルデカン酸アスコルビル 0.2
(18)水酸化レシチン 0.8
(19)大豆リン脂質 0.3
(20)トリ(カプリル/カプリン酸)グリセリル 0.3
(21)加水分解シルク蛋白質水溶液 5.0
(22)ユビキノン 2.0
(23)ヒアルロン酸ナトリウム 0.1
(24)マルチトール 0.9
(25)グリチルリチン酸ジカリウム 0.1
(26)甘草抽出物 0.1
(27)ツボクサ抽出物 0.1
(28)タイム抽出物 0.1
(29)ポリソルベート80 0.5
(30)オタネニンジン抽出物 0.1
(31)マジョラム抽出物 0.1
(32)酵母抽出物 0.1
(33)オウレン抽出物 0.1
(34)フェノキシエタノール 0.2
(35)パラオキシ安息香酸メチル 0.2
(36)パラオキシ安息香酸メチル 0.2
(37)ローズマリー油 0.05
(38)ベルガモット果実油 0.05
(39)クエン酸 0.02
製法:(1)〜(6)の水相成分および(7)〜(20)の油相成分をそれぞれ85℃に加熱溶解する。水相成分に油相成分を添加し、ホモミキサーを用いて乳化する。50℃まで冷却し(21)〜(39)の成分を順次添加して混合、均質化する。
(1)精製水 残量(重量%)
(2)ジプロピレングリコール 18.0
(3)トリイソステアリン酸ポリオキシエチレングリセリル 5.5
(4)イソステアリン酸ポリオキシエチレングリセリル 5.0
(5)1,3−ブチレングリコール 5.0
(6)ペンチレングリコール 0.8
(7)ポリオキシエチレン(カプリル/カプリン酸)グリセリル 3.0
(8)パンテノール 0.2
(9)モノオレイン酸ポリオキシエチレンソルビタン 0.5
(10)トリ(カプリル/カプリン酸)グリセリル 0.25
(11)大豆リン脂質 0.4
(12)トコフェロール 0.01
(13)グリチルリチン酸ジカリウム 0.1
(14)加水分解シルク蛋白質水溶液 5.0
(15)ユビキノン 2.0
(16)大豆発酵抽出物 0.1
(17)水溶性コラーゲン 0.5
(18)甘草抽出物 0.05
(19)リン酸ナトリウム 0.0025
(20)リン酸ニナトリウム 0.005
(21)クエン酸 0.01
(22)エデト酸ニナトリウム 0.05
(23)パラオキシ安息香酸メチル 0.2
製法:(1)〜(6)の水相成分および(7)〜(12)の油相成分をそれぞれ50℃に加熱溶解する。水相成分に油相成分を添加して混合、均質化する。35℃まで冷却し(13)〜(23)の成分を順次添加して混合、均質化する。
Claims (7)
- 加水分解シルク蛋白質およびユビキノンを含有することを特徴とする、皮膚外用剤。
- 加水分解シルク蛋白質が、加水分解セリシンであることを特徴とする、請求項1記載の皮膚外用剤。
- 加水分解セリシンの平均分子量が10,000〜200,000であり、かつ加水分解セリシンがアミノ酸組成としてセリンを20〜40モル%含有することを特徴とする、請求項2記載の皮膚外用剤。
- 皮膚外用剤全量に対する加水分解シルク蛋白質の含有量が0.0001〜20重量%であることを特徴とする、請求項1〜3いずれか一項に記載の皮膚外用剤。
- ユビキノンが、コエンザイムQ10であることを特徴とする、請求項1〜4いずれか一項に記載の皮膚外用剤。
- 皮膚外用剤全量に対するユビキノンの含有量が0.0001〜10重量%であることを特徴とする、請求項1〜5いずれか一項に記載の皮膚外用剤。
- さらに、甘草抽出物、大豆発酵抽出物、大豆抽出物、豆乳発酵抽出物、酵母抽出物、タイム抽出物、オタネニンジン抽出物、マジョラム抽出物およびツボクサ抽出物から選択される1種以上を含有する、請求項1〜6いずれか一項に記載の皮膚外用剤。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005157120A JP2006328024A (ja) | 2005-05-30 | 2005-05-30 | 皮膚用外用剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005157120A JP2006328024A (ja) | 2005-05-30 | 2005-05-30 | 皮膚用外用剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006328024A true JP2006328024A (ja) | 2006-12-07 |
Family
ID=37550096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005157120A Pending JP2006328024A (ja) | 2005-05-30 | 2005-05-30 | 皮膚用外用剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006328024A (ja) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007204432A (ja) * | 2006-02-02 | 2007-08-16 | Shiseido Co Ltd | 可溶化化粧料 |
| JP2008115113A (ja) * | 2006-11-06 | 2008-05-22 | Pola Chem Ind Inc | 乳化剤形の皮膚外用剤 |
| JP2009013100A (ja) * | 2007-07-04 | 2009-01-22 | Pola Chem Ind Inc | 水中油乳化剤形の皮膚外用剤 |
| WO2009025277A1 (ja) * | 2007-08-22 | 2009-02-26 | Kaneka Corporation | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
| EP2100592A1 (de) * | 2008-03-11 | 2009-09-16 | Coty Prestige Lancaster Group GmbH | Kosmetikum mit Anti-Alterungswirkung |
| JP2011006353A (ja) * | 2009-06-25 | 2011-01-13 | Seiren Co Ltd | セリシン由来のポリペプチドおよび角層剥離酵素保護剤 |
| WO2011132718A1 (ja) * | 2010-04-20 | 2011-10-27 | 株式会社カネカ | 還元型補酵素q10含有組成物とその製造方法及び安定化方法 |
| JP2012046544A (ja) * | 2011-11-29 | 2012-03-08 | Toyobo Co Ltd | 植物由来の賦活化剤及び細胞外マトリックス産生促進剤 |
| JP2016008188A (ja) * | 2014-06-24 | 2016-01-18 | 株式会社ノエビア | 肌理改善剤、表皮ターンオーバー改善剤、表皮バリア機能改善剤、抗酸化剤、及び皮膚外用剤 |
| JP2016210695A (ja) * | 2015-04-30 | 2016-12-15 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| JP2018127407A (ja) * | 2017-02-07 | 2018-08-16 | 日華化学株式会社 | 表皮正常化剤並びにこれを含有する外用剤及び化粧料 |
| CN108743516A (zh) * | 2018-07-20 | 2018-11-06 | 广州澳希亚实业有限公司 | 具有抗衰平纹作用的组合物及其制备方法和应用 |
| CN109106622A (zh) * | 2018-11-02 | 2019-01-01 | 广州艾蓓生物科技有限公司 | 一种具有保湿修复卸妆乳及其制备方法 |
| JPWO2018020903A1 (ja) * | 2016-07-29 | 2019-05-09 | セーレン株式会社 | 皮膚外用剤 |
| JPWO2019045020A1 (ja) * | 2017-08-30 | 2020-03-26 | 富士フイルム株式会社 | 皮膚用化粧料及び化粧料のハリ感の評価方法 |
| KR20200041667A (ko) * | 2018-10-12 | 2020-04-22 | 주식회사 세리코 | 피부 개선용 화장료 조성물 및 이의 제조 방법 |
| JP2020142995A (ja) * | 2019-03-04 | 2020-09-10 | 株式会社ノエビア | 皮膚外用剤 |
| KR20210084257A (ko) * | 2019-12-27 | 2021-07-07 | 오성음 | 피부 손상 개선 또는 보호용 화장료 조성물 및 이의 제조방법 |
| JP2022082366A (ja) * | 2020-11-20 | 2022-06-01 | ポーラ化成工業株式会社 | シミ改善作用を有する成分のスクリーニング方法 |
| JP2022143798A (ja) * | 2021-03-18 | 2022-10-03 | セーレン株式会社 | 皮膚外用剤 |
| JP2022151456A (ja) * | 2021-03-26 | 2022-10-07 | 株式会社ピカソ美化学研究所 | 皮膚用組成物 |
| CN117797066A (zh) * | 2022-12-29 | 2024-04-02 | 太和康美(北京)中医研究院有限公司 | 人参积雪草组合物及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003176218A (ja) * | 2001-12-12 | 2003-06-24 | Aioi Hakko:Kk | 皮膚外用剤 |
| JP2004099564A (ja) * | 2002-09-12 | 2004-04-02 | Nikko Chemical Co Ltd | 保湿化粧料 |
| JP2005053842A (ja) * | 2003-08-05 | 2005-03-03 | Asahi Kasei Chemicals Corp | 皮膚化粧料 |
-
2005
- 2005-05-30 JP JP2005157120A patent/JP2006328024A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003176218A (ja) * | 2001-12-12 | 2003-06-24 | Aioi Hakko:Kk | 皮膚外用剤 |
| JP2004099564A (ja) * | 2002-09-12 | 2004-04-02 | Nikko Chemical Co Ltd | 保湿化粧料 |
| JP2005053842A (ja) * | 2003-08-05 | 2005-03-03 | Asahi Kasei Chemicals Corp | 皮膚化粧料 |
Cited By (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007204432A (ja) * | 2006-02-02 | 2007-08-16 | Shiseido Co Ltd | 可溶化化粧料 |
| JP2008115113A (ja) * | 2006-11-06 | 2008-05-22 | Pola Chem Ind Inc | 乳化剤形の皮膚外用剤 |
| JP2009013100A (ja) * | 2007-07-04 | 2009-01-22 | Pola Chem Ind Inc | 水中油乳化剤形の皮膚外用剤 |
| JP5364580B2 (ja) * | 2007-08-22 | 2013-12-11 | 株式会社カネカ | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
| WO2009025277A1 (ja) * | 2007-08-22 | 2009-02-26 | Kaneka Corporation | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
| JP2014012000A (ja) * | 2007-08-22 | 2014-01-23 | Kaneka Corp | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
| EP2100592A1 (de) * | 2008-03-11 | 2009-09-16 | Coty Prestige Lancaster Group GmbH | Kosmetikum mit Anti-Alterungswirkung |
| JP2011006353A (ja) * | 2009-06-25 | 2011-01-13 | Seiren Co Ltd | セリシン由来のポリペプチドおよび角層剥離酵素保護剤 |
| WO2011132718A1 (ja) * | 2010-04-20 | 2011-10-27 | 株式会社カネカ | 還元型補酵素q10含有組成物とその製造方法及び安定化方法 |
| JPWO2011132718A1 (ja) * | 2010-04-20 | 2013-07-18 | 株式会社カネカ | 還元型補酵素q10含有組成物とその製造方法及び安定化方法 |
| JP2012046544A (ja) * | 2011-11-29 | 2012-03-08 | Toyobo Co Ltd | 植物由来の賦活化剤及び細胞外マトリックス産生促進剤 |
| JP2016008188A (ja) * | 2014-06-24 | 2016-01-18 | 株式会社ノエビア | 肌理改善剤、表皮ターンオーバー改善剤、表皮バリア機能改善剤、抗酸化剤、及び皮膚外用剤 |
| JP2016210695A (ja) * | 2015-04-30 | 2016-12-15 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| JPWO2018020903A1 (ja) * | 2016-07-29 | 2019-05-09 | セーレン株式会社 | 皮膚外用剤 |
| JP7211818B2 (ja) | 2016-07-29 | 2023-01-24 | セーレン株式会社 | 皮膚外用剤 |
| JP2018127407A (ja) * | 2017-02-07 | 2018-08-16 | 日華化学株式会社 | 表皮正常化剤並びにこれを含有する外用剤及び化粧料 |
| JPWO2019045020A1 (ja) * | 2017-08-30 | 2020-03-26 | 富士フイルム株式会社 | 皮膚用化粧料及び化粧料のハリ感の評価方法 |
| JP2021181502A (ja) * | 2017-08-30 | 2021-11-25 | 富士フイルム株式会社 | 皮膚用化粧料 |
| JP7026691B2 (ja) | 2017-08-30 | 2022-02-28 | 富士フイルム株式会社 | 化粧料のハリ感の評価方法 |
| CN108743516B (zh) * | 2018-07-20 | 2021-06-01 | 广州澳希亚实业有限公司 | 具有抗衰平纹作用的组合物及其制备方法和应用 |
| CN108743516A (zh) * | 2018-07-20 | 2018-11-06 | 广州澳希亚实业有限公司 | 具有抗衰平纹作用的组合物及其制备方法和应用 |
| KR20200041667A (ko) * | 2018-10-12 | 2020-04-22 | 주식회사 세리코 | 피부 개선용 화장료 조성물 및 이의 제조 방법 |
| KR102112827B1 (ko) * | 2018-10-12 | 2020-05-25 | 주식회사 세리코 | 피부 개선용 화장료 조성물 및 이의 제조 방법 |
| CN109106622A (zh) * | 2018-11-02 | 2019-01-01 | 广州艾蓓生物科技有限公司 | 一种具有保湿修复卸妆乳及其制备方法 |
| JP2020142995A (ja) * | 2019-03-04 | 2020-09-10 | 株式会社ノエビア | 皮膚外用剤 |
| JP7356808B2 (ja) | 2019-03-04 | 2023-10-05 | 株式会社ノエビア | 皮膚外用剤 |
| KR20210084257A (ko) * | 2019-12-27 | 2021-07-07 | 오성음 | 피부 손상 개선 또는 보호용 화장료 조성물 및 이의 제조방법 |
| KR102596335B1 (ko) | 2019-12-27 | 2023-11-01 | 오성음 | 피부 손상 개선 또는 보호용 화장료 조성물 및 이의 제조방법 |
| JP2022082366A (ja) * | 2020-11-20 | 2022-06-01 | ポーラ化成工業株式会社 | シミ改善作用を有する成分のスクリーニング方法 |
| JP7574511B2 (ja) | 2020-11-20 | 2024-10-29 | ポーラ化成工業株式会社 | シミ改善作用を有する成分のスクリーニング方法 |
| JP2022143798A (ja) * | 2021-03-18 | 2022-10-03 | セーレン株式会社 | 皮膚外用剤 |
| JP2022151456A (ja) * | 2021-03-26 | 2022-10-07 | 株式会社ピカソ美化学研究所 | 皮膚用組成物 |
| CN117797066A (zh) * | 2022-12-29 | 2024-04-02 | 太和康美(北京)中医研究院有限公司 | 人参积雪草组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006328024A (ja) | 皮膚用外用剤 | |
| CN113226277B (zh) | 美白剂、透明质酸产生促进剂、胶原蛋白产生促进剂、细胞内活性氧清除剂、刺激缓解剂、皱纹改善剂、复合物、化妆品和皮肤外用剂 | |
| KR102236253B1 (ko) | 천연물 유래 추출물을 포함하는 피부 개선용 화장료 조성물 및 이의 제조방법 | |
| KR20150118293A (ko) | 천연한방약재 감초, 당귀, 고삼 혼합추출물로 항산화, 항염증억제, 주름억제, 미백 효과를 갖는 다기능 화장료 조성물 | |
| JP2009107930A (ja) | 保湿剤及び皮膚外用剤 | |
| JP3791775B2 (ja) | 皮膚外用剤 | |
| JP2003104865A (ja) | 皮膚外用剤 | |
| JP4425163B2 (ja) | 抗老化化粧料 | |
| KR101214344B1 (ko) | 쌀겨와 감초발효추출물을 포함하는 화장료 조성물 | |
| JP5117092B2 (ja) | 保湿剤、抗老化剤、美白剤、抗酸化剤、痩身剤、トリートメント剤、アルギナーゼ活性促進剤及び皮膚外用剤 | |
| JP5465037B2 (ja) | 抗老化剤、抗酸化剤、美白剤、免疫賦活剤、皮膚外用剤および機能性経口組成物 | |
| JP2002104952A (ja) | 皮膚外用剤 | |
| KR101079915B1 (ko) | 식물 혼합 추출물 및 이를 함유하는 화장료 조성물 | |
| JP2006117607A (ja) | 皮膚外用剤 | |
| JP3449967B2 (ja) | 皮膚外用剤 | |
| CN119868188A (zh) | 异叶假繁缕根提取物及其用途 | |
| JP5247548B2 (ja) | 保湿剤、抗老化剤、中性脂肪蓄積抑制剤、美白剤、抗炎症剤、皮膚外用剤、経口用剤 | |
| JP2008303180A (ja) | 美白剤、皮膚外用剤及び機能性経口組成物 | |
| JP3754025B2 (ja) | 細胞賦活剤、抗酸化剤、及び皮膚外用剤 | |
| JP2002097149A (ja) | 皮膚外用剤 | |
| JP4970442B2 (ja) | 美白剤 | |
| JP2009215251A (ja) | 抗炎症剤及び抗炎症用皮膚外用剤 | |
| JP2006241033A (ja) | くすみ改善用皮膚外用剤 | |
| JP5202180B2 (ja) | 保湿剤、免疫賦活剤、抗老化剤、美白剤、抗酸化剤、痩身剤、皮膚外用剤及び機能性経口組成物 | |
| JP2009057309A (ja) | 皮膚外用剤及び保湿剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080526 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100715 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100803 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100928 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101207 |
